<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04974476</url>
  </required_header>
  <id_info>
    <org_study_id>20210038</org_study_id>
    <nct_id>NCT04974476</nct_id>
  </id_info>
  <brief_title>Onsite vs. Virtual Group Fitness in Overweight/Obese Women</brief_title>
  <official_title>A Comparison of Onsite vs. Virtual Fitness Program on Anthropometric Measures, Aerobic Fitness, and Vascular Markers of Cardiac Risk Markers in Overweight/Obese Premenopausal Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare an onsite to virtual whole-body high intensity&#xD;
      interval training (HIIT) program on anthropometric variables, aerobic fitness measures, and&#xD;
      vascular markers of cardiac risk in a single study of overweight and obese women.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 24, 2021</start_date>
  <completion_date type="Actual">November 8, 2021</completion_date>
  <primary_completion_date type="Actual">November 8, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pulse Wave Velocity (PWV)</measure>
    <time_frame>Up to 12 weeks</time_frame>
    <description>vascular marker of cardiac risk will be reported as PWV (m/s) as measured using SphygmoCor</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pulse Wave Analysis Augmentation Index (AIx)</measure>
    <time_frame>Up to 12 weeks</time_frame>
    <description>vascular marker of cardiac risk will be reported as AIx (%) as measured using SphygmoCor</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pulse Wave Analysis Mean Arterial Pressure (MAP)</measure>
    <time_frame>Up to 12 weeks</time_frame>
    <description>vascular marker of cardiac risk will be reported as MAP (mmHg) as measured using SphygmoCor</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visceral Adipose Tissue (VAT) content</measure>
    <time_frame>Up to 12 weeks</time_frame>
    <description>Anthropometric measure will be reported as VAT content as measured by noninvasive direct segmental multi-frequency bioelectrical impedance body composition analyzer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Adiposity</measure>
    <time_frame>Up to 12 weeks</time_frame>
    <description>Anthropometric measure will be reported as Total Adiposity as measured by noninvasive direct segmental multi-frequency bioelectrical impedance body composition analyzer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Aerobic Fitness</measure>
    <time_frame>Up to 12 weeks</time_frame>
    <description>Aerobic Fitness level as measured by the 20 meter shuttle run</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Overweight and Obesity</condition>
  <arm_group>
    <arm_group_label>In-person exercise training group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants in this group will receive in person exercise HIIT training 3 days a week for 12 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Virtual exercise training group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants in this group will receive virtual exercise HIIT training 3 days a week for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>HIIT Exercise Training</intervention_name>
    <description>The HIIT total session duration will be approximately 30 minutes and will be composed of 10 sets of 60 seconds of high-intensity exercises, &gt;80% of maximum heart rate (MHR), interspersed with a recovery period of 60 seconds of low-intensity exercise at 60% of MHR.</description>
    <arm_group_label>In-person exercise training group</arm_group_label>
    <arm_group_label>Virtual exercise training group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Premenopausal adult females over the age of 18 and under the age of 45 with a BMI&#xD;
             greater than or equal to 25 and a waist circumference greater than or equal to 35&#xD;
             inches.&#xD;
&#xD;
          -  No medical contraindications to participation in an exercise program including major&#xD;
             medical illnesses (i.e. cardiovascular disease, stroke, cancer, etc.)&#xD;
&#xD;
          -  Ability to provide informed consent&#xD;
&#xD;
          -  Willingness and ability to participate in an interval training in-person group fitness&#xD;
             exercise program 3x/week for 12 weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Adults unable to consent or mini-mental score less than 18.&#xD;
&#xD;
          -  Individuals who are not yet adults (infants, children, teenagers)&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Post-menopausal women&#xD;
&#xD;
          -  Do not speak English&#xD;
&#xD;
          -  Prisoners&#xD;
&#xD;
          -  Subjects on medicines (serum glucose, insulin, weight loss medicines, beta-blockers)&#xD;
             and having any medical pre-conditions that would interfere with one's capacity to&#xD;
             exercise.&#xD;
&#xD;
          -  Answer &quot;Yes&quot; to any of the questions on the Pre-Activity Screening Questionnaire&#xD;
             (PASQ)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arlette C Perry</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Coral Gables</city>
        <state>Florida</state>
        <zip>33134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>July 14, 2021</study_first_submitted>
  <study_first_submitted_qc>July 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2021</study_first_posted>
  <last_update_submitted>November 9, 2021</last_update_submitted>
  <last_update_submitted_qc>November 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Arlette Perry</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Exercise Program</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

